.Novo Nordisk is actually continuing its push in to genetic medicines, consenting to compensate Nano...
.Innovent Biologics has actually made the situation that its own gate inhibitor-cytokine combination...
.A phase 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.Five months after Rakovina Therapeutics pivoted toward artificial intelligence, the cancer-focused ...
.Ascendis Pharma has become a possible hazard to BioMarin's Voxzogo, reporting phase 3 development p...
.Though Alkeus Pharmaceuticals' oral eye disease property stopped working to considerably decrease g...
.Along with a trio of biotechs striking the Nasdaq on Friday, it was easy to overlook a smaller-scal...
.Immune checkpoint preventions are the superheroes of cancer cells treatment. Medications like Brist...
.Welcome to this week's Chutes & Ladders, our summary of substantial leadership hirings, shooting...
.Regeneron is actually back with lasting consequence for its own LAG-3 prevention as well as PD-1 in...